COMMUNIQUÉS West-GlobeNewswire

Medtronic Enters Into Definitive Agreement to Acquire Titan Spine
09/05/2019
Acquisition Further Accelerates Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN - May 9, 2019 - Medtronic plc (NYSE:MDT), a global leader in medical [...]
Adynxx, Inc. Receives Nasdaq Notice of Delisting or Failure to Satisfy an Initial Listing Rule or Standard
09/05/2019
SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq:ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for [...]
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
09/05/2019
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Jamieson Wellness Inc. Announces Voting Results from 2019 Annual Meeting of Shareholders
09/05/2019
TORONTO, May 09, 2019 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“ Jamieson Wellness ” or the “ Company ”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of [...]
FibroGen Reports First Quarter 2019 Financial Results
09/05/2019
Positive topline results from pooled safety analyses of roxadustat Phase 3 global program Completed one year of treatment in Phase 2 trial evaluating pamrevlumab in treatment of non-ambulatory DMD patients Conference [...]
FibroGen Announces Positive Topline Results from Pooled Safety Analyses of Roxadustat Global Phase 3 Program
09/05/2019
MACE/MACE+ endpoints evaluated across CKD patients not on dialysis and on dialysis Superiority in time to first MACE+ versus epoetin alfa in incident dialysis patients SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- [...]
Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update
09/05/2019
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the first quarter ended March 31, 2019 and provided a business update. Dr. Dennis J. [...]
Translate Bio Announces First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
-- Completed dosing in single-ascending dose portion of Phase 1/2 clinical trial in cystic fibrosis; data expected 3Q19 -- LEXINGTON, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical- [...]
BioCryst Completes Phase 1 Clinical Trial of Galidesivir
09/05/2019
RESEARCH TRIANGLE PARK, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the completion of a randomized, placebo-controlled Phase 1 clinical trial to evaluate [...]
Zafgen Reports First Quarter 2019 Operating and Financial Results
09/05/2019
Recently announced positive results for second cohort of Phase 2 clinical trial of ZGN-1061 Company is currently in the formal regulatory process related to the clinical hold for ZGN-1061; Update still anticipated in Q2 [...]
Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results
09/05/2019
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]
CytomX Therapeutics Announces First Quarter 2019 Financial Results
09/05/2019
Company to Host a Conference Call Today, May 9, 2019, at 5:00 p.m. EDT / 2:00 p.m. PDT SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology- [...]
Spero Therapeutics Announces First Quarter 2019 Operating Results and Provides Pipeline Review
09/05/2019
SPR994 pivotal Phase 3 trial underway and screening patients; multiple clinical catalysts ahead in 2H19 CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical- [...]
Calithera Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights
09/05/2019
--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on May 9, 2019-- SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a [...]
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting
09/05/2019
~ Results Demonstrate Long-term Treatment with KEVEYIS is Efficacious and Provides Durable Reduction in Attack Frequency and Severity in Patients with PPP ~ DUBLIN, Ireland and TREVOSE, Pa., May 09, 2019 (GLOBE NEWSWIRE [...]
Cerecor Reports First Quarter 2019 Results
09/05/2019
- Positive interim results from the Phase l study of CERC-301 in nOH -Positive results from Phase I Safety Data for CERC-801 in Healthy Volunteers ROCKVILLE, Md., May 09, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: [...]
ICU Medical, Inc. Announces First Quarter 2019 Results
09/05/2019
SAN CLEMENTE, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Opiant Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
SANTA MONICA, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today reported [...]
HTG Molecular Diagnostics Reports First Quarter 2019 Results
09/05/2019
Call scheduled for today, May 9, at 4:30pm ET TUCSON, Ariz., May 09, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, [...]

Pages